Search by Drug Name or NDC

    NDC 11673-0640-08 severe cold and flu 325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1 Details

    severe cold and flu 325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1

    severe cold and flu is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Target Corporation. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 11673-0640
    Product ID 11673-640_a98581ac-bd46-4bc3-8242-3e02af4beea0
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name severe cold and flu
    Proprietary Name Suffix daytime
    Non-Proprietary Name acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 325; 10; 200; 5
    Active Ingredient Units mg/1; mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Target Corporation
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2023-12-31

    Package

    NDC 11673-0640-08 (11673064008)

    NDC Package Code 11673-640-08
    Billing NDC 11673064008
    Package 2 BLISTER PACK in 1 CARTON (11673-640-08) / 12 TABLET, FILM COATED in 1 BLISTER PACK
    Marketing Start Date 2014-02-27
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 9e0118d1-3cfe-48cc-b59f-5ea7c51c2d82 Details

    Revised: 8/2022